REBOA in Nontraumatic OHCA

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 234 participants.

Also called NCT06031623

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 234 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06031623
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06031623. Randomized; no masking; primary purpose treatment. Start 2023-10-17 (actual); primary completion 2025-10-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
REBOA in Nontraumatic OHCA
Acronym
REBOA
Condition
Cardiopulmonary Arrest
Intervention (Device)
REBOA
Lead sponsor
Seoul National University Hospital (class: other)
Collaborator
Far Eastern Memorial Hospital (class: other)

Record details

Record id
cardio:ct-nct06031623
Content hash
1bf8a1abed557800167e4a9b551a5cdb2e12346bd6d425f5046efb1804954a5c